Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Follicular 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

fludarabine phosphate 52Cyclophosphamide 52Peripheral Blood Stem Cell Transplantation 50Rituximab 47Mycophenolic Acid 34Whole-Body Irradiation 33Tacrolimus 26Cyclosporine 25Busulfan 23Etoposide 21Filgrastim 19Methotrexate 18Melphalan 18Antilymphocyte Serum 18Radiotherapy 15Bortezomib 15Sirolimus 12Lenalidomide 11ibrutinib 9Flow Cytometry 9Cyclosporins 9Everolimus 8Dexamethasone 8Carboplatin 8sargramostim 7Polymerase Chain Reaction 7Methylprednisolone 7Indium 7Cytarabine 7idelalisib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Waldenstrom Macroglobulinemia × Bleomycin × Other hematologic neoplasm × Clear all
NCT00002657 2013-01-24

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

SWOG Cancer Research Network

Phase 2 Completed
20 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡